Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $215 | $266 | $94 | $489 |
| % Growth | -19.3% | 183.7% | -80.9% | – |
| Cost of Goods Sold | $160 | $183 | $44 | $387 |
| Gross Profit | $54 | $83 | $50 | $102 |
| % Margin | 25.3% | 31.3% | 53.3% | 20.9% |
| R&D Expenses | $302 | $329 | $211 | $104 |
| G&A Expenses | $8,664 | $7,369 | $2,411 | $788 |
| SG&A Expenses | $9,361 | $8,410 | $2,609 | $969 |
| Sales & Mktg Exp. | $697 | $1,042 | $197 | $95 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,663 | $8,740 | $2,819 | $1,072 |
| Operating Income | -$9,608 | -$8,656 | -$2,769 | -$970 |
| % Margin | -4,478.1% | -3,257.4% | -2,956.8% | -198.3% |
| Other Income/Exp. Net | -$2,735 | -$444 | -$34 | -$31 |
| Pre-Tax Income | -$12,344 | -$9,101 | -$2,803 | -$1,002 |
| Tax Expense | $0 | $0 | $0 | $2 |
| Net Income | -$12,344 | -$9,101 | -$2,803 | -$1,004 |
| % Margin | -5,753% | -3,424.6% | -2,992.6% | -205.2% |
| EPS | -12.95 | -25.21 | -8.88 | -4.44 |
| % Growth | 48.6% | -183.9% | -100% | – |
| EPS Diluted | -12.95 | -25.21 | -8.88 | -4.44 |
| Weighted Avg Shares Out | 953 | 361 | 316 | 226 |
| Weighted Avg Shares Out Dil | 953 | 361 | 316 | 226 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,605 | $558 | $29 | $33 |
| Depreciation & Amortization | $825 | $220 | $17 | $1 |
| EBITDA | -$7,934 | -$8,323 | -$2,752 | -$969 |
| % Margin | -3,697.6% | -3,132% | -2,938.3% | -198% |